Kim Kremer Elliott’s Post

An excellent resource for a common counselling topic: how to use heat for muscle pain.

More diabetes patients now have access to dapagliflozin under the Pharmaceutical Benefits Scheme (PBS), with restrictions easing on its use with metformin this month. https://lnkd.in/dsvgrwmx

The FDA's Office of Pharmaceutical Quality (OPQ) released its comprehensive 2023 report on the state of pharmaceutical quality, highlighting key trends, achievements, and ongoing challenges in the industry. This annual report is crucial for understanding how well pharmaceutical manufacturers adhere to quality standards that ensure the safety, efficacy, and availability of medications. In this blog we break down the main findings and insights from the report. Read more here: https://lnkd.in/eUAGE4tf

The Pharmaceutical Care Management Association (PCMA) released the following statement on the inclusion of substantial, misguided policies targeting prescription drug benefits, in both Medicare and the commercial marketplace, in the text of a proposed government funding package. https://lnkd.in/eiv9E9xY

In the ever-evolving pharmaceutical industry, finding a reliable Active Pharmaceutical Ingredient (API) supplier is crucial for the success of your business. Whether you’re a pharmaceutical manufacturer, a research institution, or a healthcare provider, the quality and consistency of your APIs can make or break your products and reputation. This comprehensive guide will walk you through the essential steps and considerations for identifying and partnering with a reputable API supplier. https://lnkd.in/ecSDjf4k

Please read our recent reveiw article "Essential oils: a potential alternative with promising active ingredients for pharmaceutical formulations in chronic wound management" published online in Inflammopharmacology using the following SharedIt link: https://rdcu.be/dUTqs

In case anyone needs to be reminded that #drugpricing is complex, here is the Producer Price Index (#PPI) for Pharmaceutical Preparation Manufacturing (price received by pharmaceutical manufacturers) and Pharmacies and Drug Retailers (price received by retailers) along with the Consumer Price Index (#CPI) for Prescription Drugs (price paid by consumers out of pocket or by third party payers including insurance or government). (Data accessed 3/21/2024). What do you think? Bentley University Center for Health and Business Center for Integration of Science and Industry at Bentley University @Bentley University

New study, "Beyond the Prescription," by MAGNA Media Trials, in partnership with DeepIntent, reveals that pharmaceutical ads significantly influence patient behavior and health management. Key findings show that 63% of patients learn about new medications from these ads, and 55% discover new health conditions thanks to them. Learn more about the impact of pharmaceutical ads here: https://lnkd.in/eZJUUFQE

- In May'24, the Indian Pharmaceutical Market (IPM) showcased robust 5.2% value growth, reaching a notable value of 16,712 Cr. - The overall growth of 5.2% for the month of May’24 is majorly contributed by Price rise and New introductions. Presenting the 12th edition of “Acquaint”, a market insight comprehensive report of the Indian pharmaceutical industry, all through the lens of PharmaTrac – Secondary Sales Audit #IndianPharmaceuticals #PharmAnalytics #PharmInsights #IPM #Pharmarack

Our focus group study, published in the Journal of Pharmaceutical Policy and Practice, qualitatively identified the barriers to medication adherence and the factors influencing the choice of lipid-lowering agents among patients with hypercholesterolemia in Hong Kong. The findings provide valuable insights for designing a large-scale DCE preference study to model the relative importance of the attributes of lipid-lowering agents. https://lnkd.in/gghp4Uux A big thank you to the team for their collective effort in making this possible! Eunice Deng Esther W Chan Lydia Fung HKU Centre for Safe Medication Practice and Research (CSMPR)